SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031742
Filing Date
2023-11-14
Accepted
2023-11-14 06:07:58
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20230930_10q.htm   iXBRL 10-Q 1811433
2 EXHIBIT 2.1 ex_591207.htm EX-2.1 440165
3 EXHIBIT 31.1 ex_587342.htm EX-31.1 8072
4 EXHIBIT 31.2 ex_587343.htm EX-31.2 8074
5 EXHIBIT 32.1 ex_587344.htm EX-32.1 6108
  Complete submission text file 0001437749-23-031742.txt   8213527

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20230930.xsd EX-101.SCH 56947
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20230930_cal.xml EX-101.CAL 68641
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20230930_def.xml EX-101.DEF 410263
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20230930_lab.xml EX-101.LAB 388314
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20230930_pre.xml EX-101.PRE 437405
54 EXTRACTED XBRL INSTANCE DOCUMENT acrx20230930_10q_htm.xml XML 1294031
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 231401369
SIC: 2834 Pharmaceutical Preparations